SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-14-002612
Filing Date
2014-12-22
Accepted
2014-12-22 17:26:55
Documents
1
Group Members
DEERFIELD INTERNATIONAL MASTER FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND II, L.P.DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e613190_sc13ga-auspex.htm SC 13G/A 425241
  Complete submission text file 0001193805-14-002612.txt   426890
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A

Mailing Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037
Business Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037 (858) 558-2400
Auspex Pharmaceuticals, Inc. (Subject) CIK: 0001454189 (see all company filings)

IRS No.: 954862842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87930 | Film No.: 141303936
SIC: 2834 Pharmaceutical Preparations